Integra LifeSciences Holdings Earnings Preview

Integra LifeSciences Holdings (Nasdaq: IART  ) only managed to meet estimates last quarter, but investors hope that it will surpass expectations this quarter. The company will unveil its latest earnings on Thursday, Feb. 23. Integra LifeSciences Holdings is a medical device company, which is engaged in the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments.

What analysts say:

  • Buy, sell, or hold?: Analysts think investors should stand pat on Integra LifeSciences Holdings, with nine out of 14 analysts rating it hold. While analysts still rate the stock a hold, they are a little more optimistic about it compared to three months ago.
  • Revenue forecasts: On average, analysts predict $202 million in revenue this quarter. That would represent a rise of 4.1% from the year-ago quarter.
  • Wall Street earnings expectations: The average analyst estimate is earnings of $0.67 per share. Estimates range from $0.65 to $0.69.

What our community says:
CAPS All-Stars are solidly behind the stock, with 93.9% granting it an outperform rating. The community at large backs the All-Stars, with 92.8% assigning it a rating of outperform. Fools are impressed with Integra LifeSciences Holdings, though the message boards have been quiet lately, with only one post in the past 30 days. Integra LifeSciences Holdings has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.

Management:
Integra LifeSciences Holdings' income has fallen year over year by an average of 33% over the past five quarters. Revenue has now gone up for three straight quarters.

Now let's look at how efficient management is at running the business. Margins illustrate how efficiently a company captures portions of sales dollars. Integra LifeSciences Holdings has seen decreasing operating margins year over year for the last four quarters. Operating margins reflect the total sales revenue that the company retains after costs. See how Integra LifeSciences Holdings has been doing for the last four quarters:

Quarter

Q3

Q2

Q1

Q4

Gross Margin

61.1%

62.3%

64.1%

63.3%

Operating Margin

9%

4.1%

11.5%

12.4%

Net Margin

5.6%

0.4%

6.3%

9.7%

We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Integra LifeSciences Holdings now.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Earnings estimates provided by Zacks.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 1783976, ~/Articles/ArticleHandler.aspx, 7/26/2014 11:43:56 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

TREND TRACKER: Get Rich When the Web Goes Dark

It's time to say "goodbye" to your Internet! One bleeding-edge technology is about to put the World Wide Web to bed. And if you act right away, it could make you wildly rich. Experts are calling it the single largest business opportunity in the history of capitalism… The Economist is calling it "transformative"... but you'll probably just call it "how I made my millions." Big money is already on the move. Don't be too late to the party – find out the 1 stock to own when the Web goes dark.


Advertisement